Our results revealed that sPD-L1, sTIM-3 and sMMP-7 levels are significantly increased in patients with severe COVID-19, and these markers could be helpful for distinguishing patients that need IMV from those who do not. This evidence concerns the gene SPDL1 and COVID-19.